{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:08:03Z","timestamp":1761887283619,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.nrleng.2020.04.023","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T04:54:32Z","timestamp":1619153672000},"page":"462-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group"],"prefix":"10.1016","volume":"36","author":[{"given":"M.","family":"Rodr\u00edguez-Ya\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"G\u00f3mez-Choco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"L\u00f3pez-Cancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alonso de Leci\u00f1ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Arenillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Ayo-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Freijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda-Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gomis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Mart\u00ednez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Palacio-Portilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Roquer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Segura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Serena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vivancos-Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2020.04.023_bib0005","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIR.0000000000000312","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"133","author":"Halperin","year":"2016","journal-title":"Circulation"},{"issue":"138","key":"10.1016\/j.nrleng.2020.04.023_bib0010","first-page":"e426","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0015","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","author":"Sundstrom","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0030","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0035","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/HJH.0b013e32834000be","article-title":"The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials","volume":"29","author":"Czernichow","year":"2011","journal-title":"J Hypertens."},{"key":"10.1016\/j.nrleng.2020.04.023_bib0045","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus (ACCORD)","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0050","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0055","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive versus standard blood pressure control and cardiovascular disease outcomes among adults age 75 and older","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0000000000000881","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens."},{"key":"10.1016\/j.nrleng.2020.04.023_bib0065","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1161\/CIR.0000000000000601","volume":"138","author":"Reboussin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0070","article-title":"Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial","author":"Hermida","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0075","first-page":"1783","article-title":"Elevated blood pressure in the acute phase of stroke and the role of Angiotensin receptor blockers","volume":"94","author":"Lattanzi","year":"2013","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.STR.17.5.861","article-title":"Blood pressure course in patients with acute stroke and matched controls","volume":"17","author":"Britton","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0085","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.STR.24.9.1372","article-title":"The prognostic value of admission blood pressure in patients with acute stroke","volume":"24","author":"Carlberg","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0090","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.0000105052.65787.35","article-title":"High blood pressure in acute stroke and subsequent outcome","volume":"43","author":"Willmot","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1751-7176.2010.00394.x","article-title":"Blood pressure control in acute cerebrovascular disease","volume":"13","author":"Owens","year":"2011","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0105","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1212\/01.wnl.0000247064.53130.91","article-title":"New-onset hypertension and inflammatory response\/poor outcome in acute ischemic stroke","volume":"67","author":"Rodr\u00edguez-Ya\u00f1ez","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0110","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/STROKEAHA.115.009552","article-title":"Effect of blood pressure lowering in early ischemic stroke: meta-analysis","volume":"46","author":"Lee","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.STR.32.2.461","article-title":"Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Horn","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.2013.282543","article-title":"Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial","volume":"5","author":"He","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(14)61121-1","article-title":"Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial","volume":"385","author":"ENOS Trial Investigators","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0130","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0135","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.nrleng.2020.04.023_bib0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1474-4422(08)70263-1","article-title":"Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial","volume":"8","author":"Potter","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0145","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1161\/STROKEAHA.109.555623","article-title":"PRoFESS Study Group. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis","volume":"40","author":"Bath","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(10)70163-0","article-title":"Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial","volume":"8","author":"Robinson","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ijs.12446","article-title":"Valsartan Efficacy oN modesT blood pressUre REduction in acute ischemic stroke (VENTURE) study group. Modest blood pressure reduction with valsartan in acute ischemic stroke: a prospective, randomized, open-label, blinded-end-point trial","volume":"10","author":"Oh","year":"2015","journal-title":"Int J Stroke"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0160","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0165","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"388","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0170","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.116.08485","article-title":"Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials","volume":"69","author":"Katsanos","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0185","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0190","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result","volume":"108","author":"PATS Collaborating Group","year":"1995","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.nrleng.2020.04.023_bib0195","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.STR.0000166048.35740.a9","article-title":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES)","volume":"36","author":"Schrader","year":"2005","journal-title":"Stroke"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082100050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217358082100050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:33:02Z","timestamp":1761881582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217358082100050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S217358082100050X"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2020.04.023","relation":{},"ISSN":["2173-5808"],"issn-type":[{"type":"print","value":"2173-5808"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2020.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2020.04.031","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}